Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Clinical trial NCT07064759 · RECRUITING
Trial details
- NCT number
- NCT07064759
- Sponsor
- 4D Molecular Therapeutics
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-22
- Primary completion
- 2028-11-01
- Enrollment
- 480
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.